Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle T Martin

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|April 5, 2017
Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 InfectionMichelle T Martin, Paulina Deming
Transplantation|April 5, 2017
Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on HemodialysisMichelle T Martin, Sean Koppe
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 30, 2016
Genotype 1 hepatitis C virus and the pharmacist's role in treatmentPhoebe Sebhatu, Michelle T Martin
The Annals of Pharmacotherapy|May 9, 2017
Hepatitis C Virus Resistance Testing in Genotype 1: The Changing Role in Clinical UtilitySuzanne Molino, Michelle T Martin
Current Medical Research and Opinion|September 28, 2011
Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgeryMichelle T Martin, Edith A Nutescu
Journal of Hepatology|July 29, 2023
Pellet-based hepatitis C virus treatment with glecaprevir/pibrentasvir: A case report of an adult with short bowel syndromeMichelle T Martin, Sonalie Patel, Wadih Chacra
Gut and Liver|February 11, 2022
High Real-World Sustained Virologic Response Rate with Glecaprevir/Pibrentasvir at a Racially Diverse Urban Academic Medical CenterMichelle T Martin, Nicole Waring, Ammara Naveed
Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2021
Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C virus retreatment in decompensated cirrhosisSonalie Patel, Michelle T Martin, Steven L Flamm
International Journal of Clinical Pharmacy|February 14, 2024
A cross-sectional survey of viral hepatitis education within pharmacy curricula in the United StatesMichelle T Martin, Aileen N Pham, Jessica S Wagner
Clinical Therapeutics|June 4, 2011
Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrelMichelle T Martin, Sarah A Spinler, Edith A Nutescu
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|April 5, 2017
Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 InfectionMichelle T Martin, Paulina Deming
Transplantation|April 5, 2017
Elbasvir/Grazoprevir Use in Postliver Transplantation Patients on HemodialysisMichelle T Martin, Sean Koppe
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 30, 2016
Genotype 1 hepatitis C virus and the pharmacist's role in treatmentPhoebe Sebhatu, Michelle T Martin
The Annals of Pharmacotherapy|May 9, 2017
Hepatitis C Virus Resistance Testing in Genotype 1: The Changing Role in Clinical UtilitySuzanne Molino, Michelle T Martin
Current Medical Research and Opinion|September 28, 2011
Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgeryMichelle T Martin, Edith A Nutescu
Journal of Hepatology|July 29, 2023
Pellet-based hepatitis C virus treatment with glecaprevir/pibrentasvir: A case report of an adult with short bowel syndromeMichelle T Martin, Sonalie Patel, Wadih Chacra
Gut and Liver|February 11, 2022
High Real-World Sustained Virologic Response Rate with Glecaprevir/Pibrentasvir at a Racially Diverse Urban Academic Medical CenterMichelle T Martin, Nicole Waring, Ammara Naveed
Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2021
Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C virus retreatment in decompensated cirrhosisSonalie Patel, Michelle T Martin, Steven L Flamm
International Journal of Clinical Pharmacy|February 14, 2024
A cross-sectional survey of viral hepatitis education within pharmacy curricula in the United StatesMichelle T Martin, Aileen N Pham, Jessica S Wagner
Clinical Therapeutics|June 4, 2011
Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrelMichelle T Martin, Sarah A Spinler, Edith A Nutescu
Pageof 3